Llorens Pharmaceutical International Division, Inc. – Trademark Portfolio
Entity Type: 03
Llorens Pharmaceutical International Division, Inc. holds 19 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 19 filings in this category. Currently, 5 trademarks are registered. Notable registered marks include HEMATEX, LLORENS, DERMAGESIC, LLORENS PHARMACEUTICAL, and EVERY BODY NEEDS PROTEIN. The owner is based in Miami, FL.
6852 NW 77 COURT
Miami, FL 33166
Showing of trademarks Trademarks
Trademark Classifications
Llorens Pharmaceutical International Division, Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Llorens Pharmaceutical International Division, Inc. have?
Llorens Pharmaceutical International Division, Inc. has 19 U.S. trademarks filed with the USPTO. Of these, 5 registered, 12 abandoned, 2 cancelled.
What trademark classes does Llorens Pharmaceutical International Division, Inc. file in?
Llorens Pharmaceutical International Division, Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Llorens Pharmaceutical International Division, Inc.'s most well-known trademarks?
Llorens Pharmaceutical International Division, Inc.'s registered trademark portfolio includes well-known marks such as HEMATEX, LLORENS, DERMAGESIC, LLORENS PHARMACEUTICAL, and EVERY BODY NEEDS PROTEIN. These are among 5 currently registered trademarks in the portfolio.
What is Llorens Pharmaceutical International Division, Inc.'s trademark registration success rate?
Llorens Pharmaceutical International Division, Inc. has a 26% trademark registration rate, with 5 out of 19 resolved applications resulting in successful registration. Currently, 0 applications are pending review.